7,589.72

+9.65

+0.13%

52,221.54

+451.23

+0.87%

25,406.43

-30.57

-0.12%

2,821.76

+9.91

+0.35%

4.8880

-0.0410

-0.83%

20.12

+0.70

+3.60%

3,963.20

+64.30

+1.65%

76,820.69

-864.66

-1.11%

Crude Oil Dec 26

96.22

-7.90

-7.59%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqCM - Nasdaq Real Time Price USD

NeuroSense Therapeutics Ltd. (NRSN)

1.2900 -0.7000 (-35.18%)

As of 1:49:54 PM EST. Market Open.

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

NeuroSense to Strengthen PrimeC Canadian ALS Submission With New NfL Data

PR Newswire 5h ago

NRSN
-35.18%
NeuroSense to Present Integrated Clinical and Biomarker Evidence Shaping PrimeC's Phase 3 Development at NEALS 2026

PR Newswire 4d ago

NRSN
-35.18%
NeuroSense Files U.S. Patent Application for Traumatic Brain Injury

PR Newswire 14d ago

NRSN
-35.18%
NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones

PR Newswire 20d ago

NRSN
-35.18%
^IXIC
NeuroSense Provides Update on Nasdaq Listing Compliance

PR Newswire 30d ago

NRSN
-35.18%
^IXIC
NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference

PR Newswire 1mo ago

NRSN
-35.18%
NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference

PR Newswire 1mo ago

NRSN
-35.18%
NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS

PR Newswire 2mo ago

NRSN
-35.18%
NeuroSense Issues CEO Letter to Shareholders

PR Newswire 2mo ago

NRSN
-35.18%
NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada

PR Newswire 2mo ago

NRSN
-35.18%
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS

PR Newswire 3mo ago

NRSN
-35.18%
NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS"

PR Newswire 3mo ago

NRSN
-35.18%

Performance Overview

Return	NRSN	S&P 500 (^GSPC)
YTD	-91.61%	+11.10%
1-Year	-94.24%	+11.18%
3-Year	-86.53%	+76.14%

Mobilize your Website

View Site in Mobile | Classic

Share by: